TickerFacts.

Marker Therapeutics, Inc. (MRKR): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-12, first reflected in a filing dated 2016-11-04; 1-for-10, first reflected in a filing dated 2023-03-22. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

15.31M
Year ended 2025-12-31
+22.4%
3-year compound annual growth
47.04M2015-12-31: 3.66M2016-12-31: 7.42M2017-12-31: 9.45M2020-12-31: 47.04M2021-12-31: 7.65M2022-12-31: 8.35M2023-12-31: 8.81M2024-12-31: 8.98M2025-12-31: 15.31M15.31M
2015-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3115.31M+70.5%2026-03-18, From 2025-01-01
2024-12-318.98M+1.9%2026-03-18, From 2024-01-01
2023-12-318.81M+5.5%2025-03-31, From 2023-01-01
2022-12-318.35M+9.2%2024-03-26, From 2022-01-01
2021-12-317.65Mn/c2023-03-22, From 2021-01-01
2020-12-3147.04Mn/c2022-03-17, From 2020-01-01
No annual figure between 2017-12-31 and 2020-12-31.
2017-12-319.45M+27.4%2018-03-23, From 2017-01-01
2016-12-317.42Mn/c2018-03-23, From 2016-01-01
2015-12-313.66Mn/a2017-03-14, From 2015-01-01